With J&J’s COVID Vaccine Pause Now Lifted, The Question Is How Well The System Worked

 
• By Brenda Sandburg

Number of deaths and ICU admissions that may have been prevented without the pause is ‘striking,’ CDC advisory committee member says; ACIP votes to reaffirm use of J&J’s vaccine in persons 18 and older based on positive risk-benefit analysis and reports of only nine additional cases of TTS.

The new warning is set, but still unresolved is how the pause will reflect on the J&J vaccine and FDA in the long term. • Source: photo illustration

More from Drug Safety

More from Pink Sheet